# Sonavex

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sonavex

- Industry: Medical Devices & Equipment
- Headquarters: Baltimore, US
- Website: www.sonavex.com
- Total disclosed funding: $17M
- Latest round: Series A (Nov 14, 2024)
- Investors on record: 12

## About

Based in the US, Sonavex, Inc. is a medical device company that specializes in innovative technologies for enhancing vascular access management in dialysis patients.Founded in 2013 and headquartered in Baltimore, Maryland, Sonavex, Inc. develops advanced medical technologies for healthcare providers. The company has raised a total of USD 12.70 mn through its Series A funding round, which concluded on November 14, 2024, with notable investors including GenHenn Capital and Riptide Ventures. The company's founder, Jerry Prince, has a background in medical technology innovation, contributing to the development of their product line.Sonavex specializes in advanced medical technology, particularly focusing on their patented EchoMark and EchoSure systems. These products are designed to facilitate the collection of critical arteriovenous fistula volumetric flow rate, diameter, and depth information in dialysis clinics, enhancing the assessment of vascular access maturation. By providing actionable data through automated ultrasound technology, Sonavex empowers healthcare providers to make informed treatment decisions, ultimately improving patient outcomes. Their primary client base includes healthcare facilities specializing in dialysis, where clinicians utilize their systems to gather accurate patient data effectively. Sonavex products are marketed across various geographical regions including North America and select markets in Europe, effectively broadening their service impact within the healthcare community.Sonavex generates revenue through direct sales of its core products, primarily the EchoMark and EchoSure systems, to healthcare providers. Their business model typically involves B2B transactions where hospitals and dialysis clinics purchase these systems to enhance their patient care capabilities. The pricing structure is established around the specific offerings of their products, reflecting the value and innovation they deliver to the healthcare sector. In addition to direct sales, the company may engage in partnerships or collaborations with healthcare organizations to further extend the reach and implementation of their technology, thereby solidifying their position in the medical device market.In November 2024, Sonavex, Inc. raised USD 12.70 mn in Series A funding. The company plans to utilize this funding to expand operations and enhance its development efforts. They are currently designing new products aimed at improving vascular access management for dialysis patients and are targeting expansion into new markets across Europe and Asia by 2025. This strategic approach aims to increase their market presence and improve patient outcomes through advanced medical technology.

## Funding rounds

- Series A, Nov 14, 2024, $13M — Partners Investment, Unorthodox Ventures, Riptide Ventures, Jastar Capital, GenHenn Capital
- Series A, Mar 9, 2018, $1M — Fusion Fund, FundRx
- Series A, Apr 24, 2017, $3.5M — Abell Foundation, CRCM, Dingman Center Angels, Grey Sky Venture Partners, Maryland Technology Development Corporation

## Investors

- Abell Foundation — Series A
- CRCM (https://capitalatlas.ai/funds/crcm) — Series A
- Dingman Center Angels — Series A
- Grey Sky Venture Partners (https://capitalatlas.ai/funds/grey-sky-venture-partners) — Series A
- Maryland Technology Development Corporation — Series A
- Fusion Fund (https://capitalatlas.ai/funds/fusion-fund) — Series A
- FundRx (https://capitalatlas.ai/funds/fundrx) — Series A
- Partners Investment (https://capitalatlas.ai/funds/partners-investment) — Series A
- Unorthodox Ventures (https://capitalatlas.ai/funds/unorthodox-ventures) — Series A
- Riptide Ventures (https://capitalatlas.ai/funds/riptide-ventures) — Series A
- Jastar Capital — Series A
- GenHenn Capital — Series A